Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04260451
Other study ID # SMC2019-07-182-009
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2, 2020
Est. completion date May 31, 2021

Study information

Verified date July 2021
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pulmonary complications are the most common complication in thoracic surgery and the leading cause of mortality.Therefore, lung protection is utmost important, and protective ventilation is strongly recommended in thoracic surgery. Protective ventilation is a prevailing ventilatory strategy in these days and is comprised of small tidal volume, limited inspiratory pressure, and application of positive end-expiratory pressure. However, several retrospective studies recently suggested that tidal volume, inspiratory pressure, and positive end-expiratory pressure are not related to patient outcomes, or only related when they influenced the driving pressure. Recently, the investigators reported the first prospective study about the driving pressure-guided ventilation in thoracic surgery. PEEP was titrated to bring the lowest driving pressure in each patient and applied throughout the one lung ventilation. The application of individualized PEEP reduced the incidence of pulmonary complications.However, that study was small size single center study with 312 patients. Thus, investigators try to perform large scale multicenter study. Through this study investigators evaluate that driving pressure-guided ventilation can reduce the incidence of postoperative pulmonary complications compared with conventional protective ventilation in thoracic surgery.


Description:

Nowdays, the usual setting of protective ventilation during one lung ventilation is tidal volume (VT) 5 ml/kg of predicted body weight, positive end-expiratory pressure (PEEP) 5 cm H2O and plateau pressure (Pplat) less than 25 cmH2O. However, a high incidence of postoperative pulmonary complications is still being observed even with a protective ventilatory strategy. Driving pressure is [Pplat - PEEP] and is the pressure required for the alveolar opening. Static lung compliance (Cstat) is expressed as [VT / (Pplat - PEEP)]. Thus, driving pressure is also expressed as [VT / Cstat]. Driving pressure has an inverse relationship with Cstat and orthodromic relationship with VT according to this formula. High driving pressure indicates poor lung condition with decreased lung compliance. Thus, investigator try to prove that driving pressure limited ventilation is superior in preventing postoperative pulmonary complications to existing protective ventilation in large scale multicenter study. Recruit maneuver perform all group after intubation (stepwise increase of positive end expiratory pressure 5,10,15 cmH2O with tidal volume 5mL/kg). The control arm receives existing conventional protective ventilation with tidal volume of 5mL/kg of ideal body weight and PEEP of 5 cmH2O during one-lung ventilation. The driving pressure arm receives driving pressure limited ventilation with tidal volume of 5mL/kg of ideal body weight and individualized PEEP. Individualized PEEP is adjusted to minimize driving pressure, it find through decremental PEEP titration from 10 to 2 cmH2O during one-lung ventilation.


Recruitment information / eligibility

Status Completed
Enrollment 1300
Est. completion date May 31, 2021
Est. primary completion date April 15, 2021
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: Adults older than or equal to 19 years with American Society of Anesthesiologists physical status ?-? Patient who undergoes one-lung ventilation (more than 60 minutes) for elective thoracic surgery Exclusion Criteria: 1. The American Society of Anesthesiologists (ASA) Physical Status classification greater than or equal to 4 2. Symptoms of heart failure (hypertension, urination, pulmonary edema, left ventricular outflow rate <45%) or preoperative vasopressors 3. Patient who is received oxygen therapy and ventilation care 4. large emphysema and pneumothorax 5. pregnancy and lactation 6. patients participating in similar studies 7. Joint with other operation 8. Patient who rejects being enrolled in the study 9. Patients with elevated intracranial pressure 10. Patients with peripheral neuropathy or blood circulation disorders 11. Patients with hematology disease 12. Congenital heart disease with shunt

Study Design


Related Conditions & MeSH terms


Intervention

Other:
ventilation
Driving Pressure Limited Ventilation Positive end expiratory pressure is adjusted to minimize driving pressure, plateau pressure minus end expiratory pressure from 10 to 2 cmH2O during one-lung ventilation. 1. Lung recruitment: stepwise increase of positive end expiratory pressure 5,10,15 cmH2O with tidal volume 5mL/kg, inspiratory:expiratory 1:1, respiratory rate 10. and driving pressure up to 20 cmH2O. Then decremental PEEP titration is performed using a volume-controlled ventilation until the lowest driving pressure (plateau pressure minus PEEP) is found. This individualized PEEP is adjusted during one-lung ventilation.

Locations

Country Name City State
Korea, Republic of Samsung medical center Seoul

Sponsors (6)

Lead Sponsor Collaborator
Samsung Medical Center Asan Medical Center, Korea University Guro Hospital, Seoul National University Hospital, Severance Hospital, The Catholic University of Korea

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary the incidence of postoperative pulmonary complications Postoperative pulmonary complications are defined as one or more of the following:
Hypoxia: SpO2 < 90%
Requiring oxygen therapy: Facial mask, nasal prong, continuous positive airway pressure, non-invasive positive pressure breathing or high flow nasal oxygen supply between POD 2 and 7.
Initial ventilator supports longer than 24 h
Re-intubation
Requiring mechanical ventilation
Tracheostomy
Pneumonia
Empyema
Atelectasis requiring bronchoscopy
Acute respiratory distress syndrome
Acute lung injury
Persistent emphysema or pneumothorax or air leak requiring chest tube for 5 days or more
Prolonged pleural effusion requiring chest tube for 5 days or more
Bronchopleural fistula
Contralateral pneumothorax
Pulmonary embolism embolism
within the first 7 days after surgery
Secondary oxygenation Partial pressure of oxygen in arterial blood (PaO2, mmHg) or PaO2/Inspired oxygen fraction (PF ratio) 15 minutes after one-lung ventilation
Secondary the incidence of rescue ventilation the need for rescue ventilation to treat hypoxia (Inspired oxygen fraction 1.0, two lung ventilation, recruitment, PEEP change, Tidal volume change, continuous positive pressure ventilation, change to pressure control mode) during surgery
Secondary Cstat Lung compliance (mL/mmHg) 15 minutes after one-lung ventilation
Secondary CRP C-reactive protein (mg/L) of laboratory exam within the first 1 days after surgery
Secondary the incidence of postoperative transfusion red blood cell, fresh frozen plasma, platelet within the first 3 days after surgery
Secondary the incidence of postoperative renal complications acute kidney injury(acute kidney injury network criteria): Stage I: Diuresis < 0.5 mg/kg (6 h) or increase in serum Cr > 0.3 mg/dl. Stage II: Diuresis < 0.5 mg/kg (12 h) or basal Cr x 2 mg/dL. Stage III: Diuresis < 0.3 mg/kg (24 h) or anuria (12 h) or basal Cr x 3 mg/dL, or Cr > 4 mg/dL or renal replacement therapy. within the first 7 days after surgery
Secondary the incidence of postoperative cognitive complications diagnosed by Confusion Assessment method (CAM: positive or negative) or Medicines for treating delirium symptoms include antipsychotic drugs and benzodiazepines within the first 7 days after surgery
Secondary the incidence of postoperative surgical site complications : The CDC defines a superficial incisional surgical site infection as one which meets the following criteria.
Infection occurs within 30 days after surgery and
Involves only skin and subcutaneous tissue of the incision and
The patient has at least one of the following:
purulent drainage from the superficial incision
organisms isolated from an aseptically obtained culture of fluid or tissue from the superficial incision
at least one of the following symptoms or signs of infection: pain or tenderness, localised swelling, redness or heat, and superficial incision is deliberately opened by surgeon and is culture positive or not cultured. A culture negative finding does not meet this criterion.
diagnosis of an incisional surgical site infection by a surgeon or attending physician.
within the first 7 days after surgery
Secondary the incidence of acute myocardial infarction Acute myocardial injury with clinical evidence of acute myocardial ischemia and with detection of a rise and/or fall of cardiac troponin values with at least one value above the 99th percentile upper reference limit and at least one of the following:
Symptoms of myocardial ischemia
New ischemic ECG changes
Development of pathological Q waves
Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality in a pattern consistent with an ischemic etiology
Identification of a coronary thrombus by angiography or autopsy (not for types 2 or 3 myocardial infarctions)
within the first 7 days after surgery
Secondary the incidence of coronary thrombosis Percutaneous coronary intervention or coronary artery surgery within the first 7 days after surgery
Secondary the incidence of cerebral infarction Magnetic resonance imaging diagnosis within the first 7 days after surgery
Secondary the incidence of septic shock : A subset of sepsis (a life-threatening organ dysfunction resulting from dysregulated host responses to infection) in which underlying circulatory, cellular, and metabolic abnormalities are profound enough to substantially increase the risk of mortality. Despite adequate fluid resuscitation, patients have hypotension requiring vasopressors to maintain a mean arterial blood pressure above 65 mmHg and have an elevated serum lactate concentration of more than 2 mmol/L within the first 7 days after surgery
Secondary the incidence of new arrythmia New arrhythmias that persist for more than 2 days within the first 7 days after surgery
Secondary Length of stay in the intensive care unit and hospital the duration of hospital stay and intensive care unit stay (day) within the first 30 days after surgery
Secondary the incidence of re-admission re-admission because of surgical related problems within the first 30 days after surgery
Secondary mortality in hospital death or out of hospital within the first 30 days after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Recruiting NCT04205058 - Coffee After Pancreatic Surgery N/A
Completed NCT02565420 - Saline Versus Lactated Ringer's Solution: The SOLAR Fluid Trial N/A
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Completed NCT03662672 - Rib Raising for Post-operative Ileus N/A
Completed NCT03787849 - Epigenetics in PostOperative Pediatric Emergence Delirium N/A
Active, not recruiting NCT05886387 - a Bayesian Analysis of Three Randomised Clinical Trials of Intraoperative Ventilation
Not yet recruiting NCT05052021 - The South African Coronavirus Disease of 2019 (COVID-19) Surgical Outcomes Study
Not yet recruiting NCT03639012 - Outcomes of Carbohydrate Loading Paediatric Patients Preoperatively for Tonsillectomy and Adenoidectomy N/A
Not yet recruiting NCT03591432 - A Trial Comparing Transnasal humidified Rapid insufflation Ventilatory Exchange (THRIVE) and Apneic Oxygenation With Facemask Ventilation in Elderly Patients Undergoing Induction of Anaesthesia. N/A
Not yet recruiting NCT03275324 - Use of Integrated Pulmonary Index to Predict Post-Operative Respiratory Adverse Events in High Risk Patients N/A
Recruiting NCT02763878 - Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal Gastrectomy Phase 3
Completed NCT02947789 - Predictive Model for Postoperative Mortality N/A
Completed NCT02891187 - Visits Versus Telephone Calls for Postoperative Care N/A
Not yet recruiting NCT02542423 - Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. N/A
Completed NCT02766062 - Effects of Propofol and Sevoflurane on Early POCD in Elderly Patients With Metabolic Syndrome N/A
Recruiting NCT01934049 - Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty Phase 4
Enrolling by invitation NCT01744938 - Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice Phase 3
Completed NCT02265991 - Prospective Biomechanical Analysis of Donor-site Morbidity Following Microvascular Fibula Transplantation N/A
Unknown status NCT01268748 - Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain N/A